Tirzepatide
Price range: $200.00 through $500.00
99% Pure | USA Made | Multi Dose
Tirzepatide is a synthetic dual-agonist peptide targeting GLP-1 and GIP receptors, used in preclinical models to study glucose homeostasis, appetite regulation, and energy balance pathways. Available in 20 mg, 30 mg, and 60 mg lyophilized vials, this dual-agonist delivers precise receptor activation for in vitro and rodent assays. Each lot is USA-made, HPLC-verified to ≥ 99% purity, endotoxin-screened (< 0.1 EU/mg), and formulated for laboratory research..
| Weight | 0.011 lbs |
|---|---|
| Dimensions | 1.25 × 0.75 × 0.75 in |
| Dose | 20mg, 30mg, 60mg |
Tirzepatide
An injectable formulation containing tirzepatide. Acts as a dual GIP and GLP-1 receptor agonist. Indicated for type 2 diabetes treatment and weight management support.
Tirzepatide
An injectable formulation containing tirzepatide. Acts as a dual GIP and GLP-1 receptor agonist. Indicated for type 2 diabetes treatment and weight management support.
Tirzepatide
An injectable formulation containing tirzepatide. Acts as a dual GIP and GLP-1 receptor agonist. Indicated for type 2 diabetes treatment and weight management support.
Tirzepatide
An injectable formulation containing tirzepatide. Acts as a dual GIP and GLP-1 receptor agonist. Indicated for type 2 diabetes treatment and weight management support.
Tirzepatide
An injectable formulation containing tirzepatide. Acts as a dual GIP and GLP-1 receptor agonist. Indicated for type 2 diabetes treatment and weight management support.
Tirzepatide
An injectable formulation containing tirzepatide. Acts as a dual GIP and GLP-1 receptor agonist. Indicated for type 2 diabetes treatment and weight management support.
